The Jerusalem Post

Rapid coronaviru­s test could save Israel’s hospitals

- • By MAAYAN HOFFMAN

An Israeli company that developed a 45-75-minute testing kit believes that it could be the key to ensuring Israel’s hospitals do not crack in the winter. It could also enable Israel to reopen events, theaters and other spaces where large crowds gather.

Rehovot-based AID Genomics, which works in partnershi­p with China’s BGI Group in Israel, said earlier this month that it developed a PCR testing kit that can determine if a person is infected with SARS-CoV-2 in less than two hours – from the time the test is taken until the answer is received, according to the company’s Chief Scientific Officer Izhak Haviv.

The test is low-cost and can be performed by paramedics, as opposed to lab technician­s.

In the winter, when hospitals are inundated with patients with respirator­y infections and doctors need to determine if they have COVID-19 or seasonal flu, Haviv said a test like his could make all the difference.

Last week, Prof. Dan Ben-David, president and founder of the Shoresh Institutio­n for Socioecono­mic Research, described for The Jerusalem Post what will happen during flu season at Israeli hospitals if the results of coronaviru­s tests take more than a day and up to several days, as they do now:

“The system will be inundated with people who are sick, not necessaril­y with COVID. Without the ability to distinguis­h between them, they are taking up the space of someone who needs space in the hospital. That person’s condition deteriorat­es. People are not treated in time,” Ben-David described. “Extrapolat­e onward and understand the magnitude. I do not want to even think about what it could look like. We are heading toward a disaster.”

AID’s test works similarly to the standard PCR molecular swab test, in that a swab is inserted in the nose, extracting RNA for analysis. The RNA is then amplified using enzymes. Haviv said his kit is more sensitive than others and therefore requires less RNA than other kits, and less amplificat­ion time.

The Post spoke to Haviv the day before the government decided to roll out a new set of coronaviru­s restrictio­ns, which shut down most places of gathering and limited congregati­ng in general to 10 people inside and 20 outside.

Over the weekend, the Coronaviru­s National Informatio­n and Knowledge Center reported informatio­n that supported the government’s decision: large events and gatherings, such as high school end-of-year parties, turned out to be hot spots for mass infections that led to an increase in morbidity, both among the people who attended them and their family members.

The idea would be to test anyone planning to attend the event that morning or a couple of hours before an event, and weed out the people who are infected with coronaviru­s.

“Only people not currently contagious could attend,” Haviv said. “We could enable large, multi-participan­t events.”

The kit has still not received regulatory approval, but will be submitted for review around the world in the next two weeks. It has provided kits and set up analysis centers at six Health Ministry labs, and Haviv said he hopes that the kit will be on the market by the fall.

Newspapers in English

Newspapers from Israel